Search for: "SANDOZ, INC."
Results 441 - 460
of 679
Sort by Relevance
|
Sort by Date
2 Sep 2011, 4:27 am
Hoffmann–La Roche, Inc., 24 F.3d 463, 469 (3d Cir.1994). [read post]
1 Sep 2011, 6:14 am
The AstraZeneca settlement follows settlements by other defendants to the lawsuit, including Teva Pharmaceuticals, Barr Laboratories, Inc., and Sandoz, Inc. [read post]
30 Aug 2011, 7:50 pm
Following the Fifth Circuit's decision in Sandoz v. [read post]
30 Aug 2011, 5:18 am
Sandoz Inc., 08-7611, U.S. [read post]
24 Aug 2011, 12:33 am
The lobbying push for a PTE (FDA Law Blog) US: Generics fees: A fantastic opportunity (profitability through simplicity) USPTO announces agenda for next BCP customer partnership meeting (Patent Docs) US: GOP candidates unified in opposition to embryonic cell research (Patent Docs) US: District Court Massachusetts: Method of detecting fetal down syndrome passes muster under Bilski‘s machine-or-transformation test: PerkinElmer, Inc., et. al. v. [read post]
21 Aug 2011, 9:16 pm
Sandoz Inc. v. [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole)… [read post]
10 Jul 2011, 11:29 pm
The committee is seeking documents and information from Amphastar Pharmaceuticals, Momenta Pharmaceuticals, Siegfried USA Inc., Sagent Pharmaceutical, APP Pharmaceuticals, Sanofi Aventis, Drug Source Company LLC, Global Pharma Sourcing LLC, Pacific Rainbow International and Sandoz. [read post]
7 Jul 2011, 2:17 pm
Sandoz, Inc., 566 F.3d 1282, 1298 (Fed. [read post]
27 Jun 2011, 9:40 pm
The panel consisted of patent counsel from both brand and generic industries, including Mark Bowditch (Sandoz, Inc.), Edward Murray (Merck & Co., Inc.), and Bart Newland... [read post]
27 Jun 2011, 6:56 pm
Calcar, Inc. v. [read post]
20 Jun 2011, 7:01 pm
Sandoz, Inc. [read post]
15 Jun 2011, 4:56 am
Sandoz Inc. et al. [read post]
13 Jun 2011, 12:10 pm
Sandoz, Inc., 699 F. [read post]
2 Jun 2011, 12:46 pm
Wyeth Inc., 488 F. [read post]
1 Jun 2011, 11:22 am
Sandoz, Inc., 566 F.3d 1282, 1298 (Fed. [read post]
29 May 2011, 9:01 pm
Sandoz Inc. 1:11-cv-00424; filed May 13, 2011 in the District Court of Delaware • Plaintiffs: Abbott Laboratories; Wisconsin Alumni Research Foundation • Defendant: Sandoz Inc. [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
6 May 2011, 4:54 pm
Sandoz Inc., C.A. [read post]
